Cargando…
Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives
Cannabigerol (CBG) is a cannabinoid from the plant Cannabis sativa that lacks psychotomimetic effects. Its precursor is the acidic form, cannabigerolic acid (CBGA), which is, in turn, a biosynthetic precursor of the compounds cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC). CBGA decarboxylation...
Autores principales: | Calapai, Fabrizio, Cardia, Luigi, Esposito, Emanuela, Ammendolia, Ilaria, Mondello, Cristina, Lo Giudice, Roberto, Gangemi, Sebastiano, Calapai, Gioacchino, Mannucci, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666035/ https://www.ncbi.nlm.nih.gov/pubmed/36397993 http://dx.doi.org/10.1155/2022/3336516 |
Ejemplares similares
-
Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023) -
Suspected oncologic adverse reactions associated with interleukin‐23 inhibitors in EudraVigilance: Comparative study and gender distribution
por: Calapai, Fabrizio, et al.
Publicado: (2023) -
Response to “Evaluating Adverse Events in Databases”
por: Calapai, Fabrizio, et al.
Publicado: (2023) -
Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database
por: Calapai, Fabrizio, et al.
Publicado: (2023) -
Safety of Medical Cannabis in Neuropathic Chronic Pain Management
por: Bennici, Alessandra, et al.
Publicado: (2021)